Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages

被引:142
作者
Hirota, Keiji
Hasegawa, Taizo
Hinata, Hideyuki
Ito, Fuminori
Inagawa, Hiroyuki
Kochi, Chie
Soma, Gen-Ichiro
Makino, Kimiko
Terada, Hiroshi
机构
[1] Tokyo Univ Sci, Fac Pharmaceut Sci, Noda, Chiba 2788510, Japan
[2] Tokyo Univ Sci, Inst Drug Delivery Res, Noda, Chiba 2788510, Japan
[3] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima 7708514, Japan
[4] Natl Fisheries Univ, Yamaguchi 7596595, Japan
关键词
pulmonary delivery; alveolar macrophage; rifampicin; tuberculosis; PLGA microspheres;
D O I
10.1016/j.jconrel.2007.01.013
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We examined the phagocytic activities of alveolar macrophages (NR8383 cells) toward poly(lactic-co-glycolic) acid (PLGA) microspheres (MS) loaded with the anti-tuberculosis agent rifampicin (RFP), the sizes of which were between 1 mu m and 10 mu m. We found that 1) the phagocytosis was dependent greatly on the particle size and the number of particles added; 2) macrophages phagocytosed considerably the PLGA microspheres loaded with RFP, the diameter of which was between 1 mu m and 6 mu m, but took up few 10-mu m particles; 3) the population of the macrophages that phagocytosed 1-mu m or 3-mu m particles was larger than that of those phagocytosed 6- or 10-mu m particles; 4) a considerable population of macrophages were not able to phagocytose even the 1- and 3-mu m particles; 5) the most efficient deliveries of RFP into each macrophage cell and a large population of macrophages were achieved by the phagocytosis of 3-mu m particles; and 6) phagocytosis did not affect macrophage viability in 4 h after the start of phagocytosis. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:69 / 76
页数:8
相关论文
共 50 条
[1]   RESPONSE OF CULTURED MACROPHAGES TO MYCOBACTERIUM-TUBERCULOSIS, WITH OBSERVATIONS ON FUSION OF LYSOSOMES WITH PHAGOSOMES [J].
ARMSTRONG, JA ;
HART, PD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1971, 134 (03) :713-+
[2]   Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid polyglycolic acid copolymers [J].
Athanasiou, KA ;
Niederauer, GG ;
Agrawal, CM .
BIOMATERIALS, 1996, 17 (02) :93-102
[3]   Use of microsphere technology for targeted delivery of rifampin to Mycobacterium tuberculosis-infected macrophages [J].
Barrow, ELW ;
Winchester, GA ;
Staas, JK ;
Quenelle, DC ;
Barrow, WW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2682-2689
[4]   In vitro and in vivo evaluation of the effects of PLA microparticle crystallinity on cellular response [J].
Biggs, DL ;
Lengsfeld, CS ;
Hybertson, BM ;
Ng, KY ;
Manning, MC ;
Randolph, TW .
JOURNAL OF CONTROLLED RELEASE, 2003, 92 (1-2) :147-161
[5]   A quantitative luminescence assay for measuring cell uptake of aqueous-based microcapsules in vitro [J].
Brubaker, JO ;
Patil, RT ;
Speaker, TJ ;
Offit, PA .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 237 (1-2) :85-93
[6]   Therapeutic efficacy of poly(DL-lactide-co-glycolide)-encapsulated antitubercular drugs against Mycobacterium tuberculosis infection induced in mice [J].
Dutt, M ;
Khuller, GK .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :363-366
[7]   A coat protein on phagosomes involved in the intracellular survival of mycobacteria [J].
Ferrari, G ;
Langen, H ;
Naito, M ;
Pieters, J .
CELL, 1999, 97 (04) :435-447
[8]  
Fortin M, 1999, CYTOMETRY, V36, P27, DOI 10.1002/(SICI)1097-0320(19990501)36:1<27::AID-CYTO4>3.3.CO
[9]  
2-5
[10]   New polymeric carriers for controlled drug delivery following inhalation or injection [J].
Fu, J ;
Fiegel, J ;
Krauland, E ;
Hanes, J .
BIOMATERIALS, 2002, 23 (22) :4425-4433